Pipeline

RNA therapeutics for complex diseases

At Nutcracker Therapeutics, we are driven by the unique opportunity that RNA offers to develop best-in-class medicines that will improve human health around the world. Because the promise of RNA isn’t the future, it’s now.

Pipeline

Program

Program

Discovery

Lead candidate identification

IND-enabling studies

Phases 1-3

NTX-0250

Target

Undisclosed

Modality

Multimodal RNA therapeutic

Indication

HPV-driven tumors

Discovery Lead candidate identification IND-enabling studies Phases 1-3

NTX-0565

Target

Undisclosed

Modality

Patient-specific multimodal RNA therapeutic

Indication

T cell lymphoma

Discovery Lead candidate identification IND-enabling studies Phases 1-3

NTX-0470

Target

Undisclosed

Modality

Multimodal RNA therapeutic

Indication

Genitourinary tumors

Discovery Lead candidate identification IND-enabling studies Phases 1-3